BOT 0.00% 22.0¢ botanix pharmaceuticals ltd

CYC share price doubled from re-filing to FDA approval. Was...

  1. 4,362 Posts.
    lightbulb Created with Sketch. 1246
    CYC share price doubled from re-filing to FDA approval. Was $1.40 on resubmission and $2.80 on FDA approval.

    CU6 is valued at double what we are with phase 3 trials.

    We have a complete response to the most minor issue on a near FDA approved product, basically de-risked selling in overseas markets already.

    Punters looking to sell out this morning are playing a dangerous game.

    This will trade up and move towards Euroz 30c price target into approval. Beyond that we are in unknown terrority.

    All in my humble opinion. Good luck folks!

 
watchlist Created with Sketch. Add BOT (ASX) to my watchlist
(20min delay)
Last
22.0¢
Change
0.000(0.00%)
Mkt cap ! $346.5M
Open High Low Value Volume
22.0¢ 22.0¢ 21.5¢ $556.8K 2.564M

Buyers (Bids)

No. Vol. Price($)
1 100000 21.5¢
 

Sellers (Offers)

Price($) Vol. No.
22.0¢ 188599 5
View Market Depth
Last trade - 16.10pm 30/04/2024 (20 minute delay) ?
Last
21.8¢
  Change
0.000 ( 1.09 %)
Open High Low Volume
22.0¢ 22.0¢ 21.5¢ 1397313
Last updated 15.59pm 30/04/2024 ?
BOT (ASX) Chart
arrow-down-2 Created with Sketch. arrow-down-2 Created with Sketch.